Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 98

2.

Dengue Human Infection Models to Advance Dengue Vaccine Development.

Larsen CP, Whitehead SS, Durbin AP.

Vaccine. 2015 Oct 27. pii: S0264-410X(15)01424-3. doi: 10.1016/j.vaccine.2015.09.113. [Epub ahead of print]

PMID:
26501186
3.

Dengue human infection models to advance dengue vaccine development.

Larsen CP, Whitehead SS, Durbin AP.

Vaccine. 2015 Dec 10;33(50):7075-82. doi: 10.1016/j.vaccine.2015.09.052. Epub 2015 Sep 28.

4.

Dengue viruses cluster antigenically but not as discrete serotypes.

Katzelnick LC, Fonville JM, Gromowski GD, Bustos Arriaga J, Green A, James SL, Lau L, Montoya M, Wang C, VanBlargan LA, Russell CA, Thu HM, Pierson TC, Buchy P, Aaskov JG, Muñoz-Jordán JL, Vasilakis N, Gibbons RV, Tesh RB, Osterhaus AD, Fouchier RA, Durbin A, Simmons CP, Holmes EC, Harris E, Whitehead SS, Smith DJ.

Science. 2015 Sep 18;349(6254):1338-43. doi: 10.1126/science.aac5017.

PMID:
26383952
5.

Soluble mediators produced by the crosstalk between microvascular endothelial cells and dengue-infected primary dermal fibroblasts inhibit dengue virus replication and increase leukocyte transmigration.

Bustos-Arriaga J, Mita-Mendoza NK, Lopez-Gonzalez M, García-Cordero J, Juárez-Delgado FJ, Gromowski GD, Méndez-Cruz RA, Fairhurst RM, Whitehead SS, Cedillo-Barrón L.

Immunol Res. 2015 Jul 1. [Epub ahead of print]

PMID:
26130295
6.

Dual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses.

Tsetsarkin KA, Liu G, Kenney H, Bustos-Arriaga J, Hanson CT, Whitehead SS, Pletnev AG.

PLoS Pathog. 2015 Apr 23;11(4):e1004852. doi: 10.1371/journal.ppat.1004852. eCollection 2015 Apr.

7.

Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.

Gromowski GD, Firestone CY, Whitehead SS.

J Virol. 2015 Jun;89(12):6328-37. doi: 10.1128/JVI.00219-15. Epub 2015 Apr 8.

8.

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults.

Kirkpatrick BD, Durbin AP, Pierce KK, Carmolli MP, Tibery CM, Grier PL, Hynes N, Diehl SA, Elwood D, Jarvis AP, Sabundayo BP, Lyon CE, Larsson CJ, Jo M, Lovchik JM, Luke CJ, Walsh MC, Fraser EA, Subbarao K, Whitehead SS.

J Infect Dis. 2015 Sep 1;212(5):702-10. doi: 10.1093/infdis/jiv082. Epub 2015 Mar 22.

PMID:
25801652
9.

Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Gromowski GD, Firestone CY, Bustos-Arriaga J, Whitehead SS.

Am J Trop Med Hyg. 2015 Jan;92(1):98-107. doi: 10.4269/ajtmh.14-0427. Epub 2014 Oct 13.

10.

Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.

Hanley KA, Guerbois M, Kautz TF, Brown M, Whitehead SS, Weaver SC, Vasilakis N, Marx PA.

Am J Trop Med Hyg. 2014 Oct;91(4):672-6. doi: 10.4269/ajtmh.13-0492. Epub 2014 Aug 4.

11.

Mechanism and significance of cell type-dependent neutralization of flaviviruses.

Mukherjee S, Dowd KA, Manhart CJ, Ledgerwood JE, Durbin AP, Whitehead SS, Pierson TC.

J Virol. 2014 Jul;88(13):7210-20. doi: 10.1128/JVI.03690-13. Epub 2014 Apr 16.

12.

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.

Gromowski GD, Firestone CY, Hanson CT, Whitehead SS.

Vaccine. 2014 May 23;32(25):3010-8. doi: 10.1016/j.vaccine.2014.03.062. Epub 2014 Mar 31.

13.

Corticosteroids for dengue - why don't they work?

Nguyen TH, Nguyen TH, Vu TT, Farrar J, Hoang TL, Dong TH, Ngoc Tran V, Phung KL, Wolbers M, Whitehead SS, Hibberd ML, Wills B, Simmons CP.

PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2592. doi: 10.1371/journal.pntd.0002592. eCollection 2013.

14.

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

VanBlargan LA, Mukherjee S, Dowd KA, Durbin AP, Whitehead SS, Pierson TC.

PLoS Pathog. 2013;9(12):e1003761. doi: 10.1371/journal.ppat.1003761. Epub 2013 Dec 5.

15.

The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.

Durbin AP, Wright PF, Cox A, Kagucia W, Elwood D, Henderson S, Wanionek K, Speicher J, Whitehead SS, Pletnev AG.

Vaccine. 2013 Nov 19;31(48):5772-7. doi: 10.1016/j.vaccine.2013.07.064. Epub 2013 Aug 19.

16.

Response to Ruiz-Alejo et al.

Durbin AP, Whitehead SS.

J Infect Dis. 2013 Oct 1;208(7):1184. doi: 10.1093/infdis/jit298. Epub 2013 Jul 11. No abstract available.

17.

Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles.

Lindow JC, Durbin AP, Whitehead SS, Pierce KK, Carmolli MP, Kirkpatrick BD.

Vaccine. 2013 Jul 18;31(33):3347-52. doi: 10.1016/j.vaccine.2013.05.075. Epub 2013 Jun 2.

18.

Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics.

Smith SA, de Alwis R, Kose N, Durbin AP, Whitehead SS, de Silva AM, Crowe JE Jr.

J Infect Dis. 2013 Jun 15;207(12):1898-908. doi: 10.1093/infdis/jit119. Epub 2013 Mar 22.

19.

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial.

Durbin AP, Kirkpatrick BD, Pierce KK, Elwood D, Larsson CJ, Lindow JC, Tibery C, Sabundayo BP, Shaffer D, Talaat KR, Hynes NA, Wanionek K, Carmolli MP, Luke CJ, Murphy BR, Subbarao K, Whitehead SS.

J Infect Dis. 2013 Mar 15;207(6):957-65. doi: 10.1093/infdis/jis936. Epub 2013 Jan 17.

20.

Replacement of conserved or variable sequences of the mosquito-borne dengue virus 3' UTR with homologous sequences from Modoc virus does not change infectivity for mosquitoes.

Tumban E, Maes NE, Schirtzinger EE, Young KI, Hanson CT, Whitehead SS, Hanley KA.

J Gen Virol. 2013 Apr;94(Pt 4):783-8. doi: 10.1099/vir.0.046664-0. Epub 2012 Dec 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk